Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.95 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.95 |
| ▸ | MEN1 | O00255 | 4/20 | 0.95 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.95 |
| ▸ | HPGD | P15428 | 4/20 | 0.95 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.95 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.95 |
| ▸ | USP2 | O75604 | 2/20 | 0.95 |
| ▸ | MAPT | P10636 | 2/20 | 0.95 |
| ▸ | CASP1 | P29466 | 2/20 | 0.95 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.95 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.95 |
| ▸ | HTT | P42858 | 2/20 | 0.95 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.95 |
| ▸ | LMNA | P02545 | 1/20 | 0.95 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.95 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.95 |
| ▸ | IDO1 | P14902 | 1/20 | 0.95 |
| ▸ | BLM | P54132 | 1/20 | 0.95 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.95 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dichlorophen SCHEMBL9109126 | 0.98 | CYP3A4 (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL29524636 | 0.98 | CYP3A4 (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL18052 | 0.98 | CYP3A4 (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL29349447 | 0.98 | CYP3A4 (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL2471883 | 0.95 | CYP3A4 (0.95) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL16619827 | 0.93 | CYP3A4 (0.91) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| SCHEMBL15459932 | 0.89 | HIF1A (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| SCHEMBL15459933 | 0.89 | HIF1A (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| Dichlorophen SCHEMBL5614299 | 0.89 | CYP3A4 (0.83) | CYP3A4HIF1AMEN1KMT2AHPGD | |
| SCHEMBL6115713 | 0.89 | HIF1A (1.00) | CYP3A4HIF1AMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1204883-C | Low dose diclofenac sodium lozenge and its preparation method | NANJING KEYUAN MEDICINAL TECHN (CN) | 2005-06-08 | — | — | CN | claimed |
| CN-1413583-A | Low dose diclofenac sodium lozenge and its preparation method | NANJING KEYUAN MEDICINAL TECHN (CN) | 2003-04-30 | — | — | CN | claimed |
| US-6096443-A | Transparencies | XEROX CORPORATION (US) | 2000-08-01 | — | — | US | claimed |
| EP-0544418-A2 | Synergistic combinations of 2-methyl-3-isothiazolone and certain commercial biocides | ROHM AND HAAS COMPANY (US) | 1993-06-02 | — | — | EP | claimed |
| JP-5246808-A | — | — | None | — | — | JP | disclosed |
| US-20250024837-A1 | PESTICIDE SYSTEM | BANISH, MICHELE | 2025-01-23 | — | — | US | disclosed |
| US-20240074434-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2024-03-07 | — | — | US | disclosed |
| US-20240065262-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2024-02-29 | — | — | US | disclosed |
| WO-2023154183-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20230172194-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY HANSON (US) | 2023-06-08 | — | — | US | disclosed |
| US-20220272987-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY H (US) | 2022-09-01 | — | — | US | disclosed |
| EP-2207416-B1 | ENHANCED RETENTION CAPABILITIES THROUGH METHODS COMPRISING SURFACE TREATMENT OF FUNCTIONAL PARTICULATE CARRIER MATERIALS, AND FUNCTIONAL PARTICULATE CARRIER MATERIALS MADE THEREFROM | IMERYS FILTRATION MINERALS INC (US) | 2018-11-07 | — | — | EP | disclosed |
| US-4929271-A | HALOPHENOXYALKANOIC ACIDS FOR CERALS | MAY & BAKER LIMITED (GB) | 1990-05-29 | — | — | US | disclosed |
| EP-0361246-A1 | Biocidal composition | COALITE PRODUCTS LIMITED (GB) | 1990-04-04 | — | — | EP | disclosed |
| EP-0292154-A2 | Herbicidal method using diflufenican | MAY & BAKER LIMITED (GB) | 1988-11-23 | — | — | EP | disclosed |
| EP-0290257-A2 | Herbicidal method comprising the use of diflufenican | MAY & BAKER LIMITED (GB) | 1988-11-09 | — | — | EP | disclosed |
| EP-0274892-A2 | Method of killing weeds comprising the use of diflufenican | MAY & BAKER LIMITED (GB) | 1988-07-20 | — | — | EP | disclosed |
| EP-0273669-A2 | Herbicidal method comprising the use of diflufenican | MAY & BAKER LIMITED (GB) | 1988-07-06 | — | — | EP | disclosed |
| EP-0273668-A2 | Herbicidal method using diflufenican | MAY & BAKER LIMITED (GB) | 1988-07-06 | — | — | EP | disclosed |
| EP-0255272-A1 | Herbicidal method comprising the use of diflufenican | MAY & BAKER LIMITED (GB) | 1988-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250024837-A1 | PESTICIDE SYSTEM | ACHE, PFAS, FPGS | CYP3A4 89/4885HIF1A 4878/4885MEN1 4754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.